0000000000299428

AUTHOR

Nikolas K. Haass

showing 3 related works from this author

Tissue expression of the vesicle protein pantophysin

1999

The cell-type restricted expression of cytoplasmic microvesicle membrane protein isoforms may be a consequence of the functional adaptation of these vesicles to the execution of specialized processes in cells of different specialization. To characterize the expression of the vesicle protein pantophysin, an isoform of the synaptic vesicle proteins synaptophysin and synaptoporin, we have prepared and characterized antibodies useful for the immunological detection of pantophysin in vitro and in situ. Using these reagents, we show by immunoblot analyses that pantophysin expression is not homogeneous but differs significantly between various bovine tissues. Furthermore, these differences are not…

Vesicle-associated membrane protein 8Membrane GlycoproteinsHistologySynaptobrevinMicrovesicleMembrane ProteinsSNAP25Cell BiologySynaptoporinBiologyCytoplasmic GranulesMolecular biologyPathology and Forensic MedicineCell biologyR-SNARE ProteinsVesicle-associated membrane proteinMembrane proteinOrgan SpecificitySynaptophysinbiology.proteinAnimalsProtein IsoformsCattleCarrier ProteinsFluorescent Antibody Technique IndirectCell and Tissue Research
researchProduct

Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha

2017

Tumor necrosis factor-alpha (TNF-α) is a pleiotropic immune stimulatory cytokine and natural endotoxin that can induce necrosis and regression in solid tumors. However, systemic administration of TNF-α is not feasible due to its short half-life and acute toxicity, preventing its widespread use in cancer treatment. Dendritic mesoporous silica nanoparticles (DMSN) are used coated with a pH-responsive block copolymer gate system combining charged hyperbranched polyethylenimine and nonionic hydrophilic polyethylenglycol to encapsulate TNF-α and deliver it into various cancer cell lines and dendritic cells. Half-maximal effective concentration (EC50 ) for loaded TNF-α is reduced by more than two…

Materials sciencemedicine.medical_treatmentBiomedical EngineeringPharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesProinflammatory cytokineBiomaterialschemistry.chemical_compoundDrug Delivery SystemsIn vivoCell Line TumorNeoplasmsmedicineHumansPolyethylenimineDose-Response Relationship DrugTumor Necrosis Factor-alphaCell CycleCell cycleMesoporous silicaSilicon Dioxide021001 nanoscience & nanotechnology0104 chemical sciencesCytokinechemistryImmunologyDrug deliveryBiophysicsNanoparticlesTumor necrosis factor alpha0210 nano-technologyPorosityAdvanced Healthcare Materials
researchProduct

Drug Delivery: Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha (Adv. Healthcare Mater. 13/2017)

2017

BiomaterialsMaterials scienceStimuli responsiveDrug deliveryBiomedical EngineeringPharmaceutical ScienceNanoparticleTumor necrosis factor alphaNanotechnologyMesoporous silicaPharmacologyProinflammatory cytokineAdvanced Healthcare Materials
researchProduct